S100A16 and neoplasm: At 5 days post injection S100A16 silenced tumors were noticeably smaller than those of the vector control cells; however, minimal differences were seen until 21 days when tumor growth was blunted as compared to controls (Fig. 4B, C and Supplemental Table 3).